These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 29695636)

  • 1. Targeting AKT with Oridonin Inhibits Growth of Esophageal Squamous Cell Carcinoma
    Song M; Liu X; Liu K; Zhao R; Huang H; Shi Y; Zhang M; Zhou S; Xie H; Chen H; Li Y; Zheng Y; Wu Q; Liu F; Li E; Bode AM; Dong Z; Lee MH
    Mol Cancer Ther; 2018 Jul; 17(7):1540-1553. PubMed ID: 29695636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. OP16, a novel ent-kaurene diterpenoid, potentiates the antitumor effect of rapamycin by inhibiting rapamycin-induced feedback activation of Akt signaling in esophageal squamous cell carcinoma.
    Peng KZ; Ke Y; Zhao Q; Tian F; Liu HM; Hou G; Lu Z
    Biochem Pharmacol; 2017 Sep; 140():16-27. PubMed ID: 28539264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oridonin-induced mitochondria-dependent apoptosis in esophageal cancer cells by inhibiting PI3K/AKT/mTOR and Ras/Raf pathways.
    Jiang JH; Pi J; Jin H; Cai JY
    J Cell Biochem; 2019 Mar; 120(3):3736-3746. PubMed ID: 30229997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oridonin inhibits oral cancer growth and PI3K/Akt signaling pathway.
    Yang J; Ren X; Zhang L; Li Y; Cheng B; Xia J
    Biomed Pharmacother; 2018 Apr; 100():226-232. PubMed ID: 29432993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oridonin triggers apoptosis in colorectal carcinoma cells and suppression of microRNA-32 expression augments oridonin-mediated apoptotic effects.
    Yang J; Jiang H; Wang C; Yang B; Zhao L; Hu D; Qiu G; Dong X; Xiao B
    Biomed Pharmacother; 2015 May; 72():125-34. PubMed ID: 26054686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acetyl-macrocalin B suppresses tumor growth in esophageal squamous cell carcinoma and exhibits synergistic anti-cancer effects with the Chk1/2 inhibitor AZD7762.
    Wang JN; Che Y; Yuan ZY; Lu ZL; Li Y; Zhang ZR; Li N; Li RD; Wan J; Sun HD; Sun N; Puno PT; He J
    Toxicol Appl Pharmacol; 2019 Feb; 365():71-83. PubMed ID: 30633885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted therapy of the AKT kinase inhibits esophageal squamous cell carcinoma growth in vitro and in vivo.
    Liu X; Song M; Wang P; Zhao R; Chen H; Zhang M; Shi Y; Liu K; Liu F; Yang R; Li E; Bode AM; Dong Z; Lee MH
    Int J Cancer; 2019 Aug; 145(4):1007-1019. PubMed ID: 30887517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oridonin induces G2/M cell cycle arrest and apoptosis in human oral squamous cell carcinoma.
    Wang H; Zhu L; Feng X; Zhang H; Luo Q; Chen F
    Eur J Pharmacol; 2017 Nov; 815():282-289. PubMed ID: 28935563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oridonin induces apoptosis and cell cycle arrest of gallbladder cancer cells via the mitochondrial pathway.
    Bao R; Shu Y; Wu X; Weng H; Ding Q; Cao Y; Li M; Mu J; Wu W; Ding Q; Tan Z; Liu T; Jiang L; Hu Y; Gu J; Liu Y
    BMC Cancer; 2014 Mar; 14():217. PubMed ID: 24655726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long noncoding RNA PTCSC1 drives esophageal squamous cell carcinoma progression through activating Akt signaling.
    Liu T; Liang X; Yang S; Sun Y
    Exp Mol Pathol; 2020 Dec; 117():104543. PubMed ID: 32971114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down-regulation of Rictor enhances cell sensitivity to PI3K inhibitor LY294002 by blocking mTORC2-medicated phosphorylation of Akt/PRAS40 in esophageal squamous cell carcinoma.
    Hou G; Zhao Q; Zhang M; Fan T; Liu M; Shi X; Ren Y; Wang Y; Zhou J; Lu Z
    Biomed Pharmacother; 2018 Oct; 106():1348-1356. PubMed ID: 30119206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oridonin Suppresses Proliferation of Human Ovarian Cancer Cells via Blockage of mTOR Signaling.
    Xia R; Chen SX; Qin Q; Chen Y; Zhang WW; Zhu RR; Deng AM
    Asian Pac J Cancer Prev; 2016; 17(2):667-71. PubMed ID: 26925661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cytostatic and cytotoxic effects of oridonin (Rubescenin), a diterpenoid from Rabdosia rubescens, on tumor cells of different lineage.
    Chen S; Gao J; Halicka HD; Huang X; Traganos F; Darzynkiewicz Z
    Int J Oncol; 2005 Mar; 26(3):579-88. PubMed ID: 15703811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oridonin inhibits BxPC-3 cell growth through cell apoptosis.
    Xu B; Shen W; Liu X; Zhang T; Ren J; Fan Y; Xu J
    Acta Biochim Biophys Sin (Shanghai); 2015 Mar; 47(3):164-73. PubMed ID: 25651847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. OP16 induces deadly autophagy and apoptosis of cells by inhibiting Akt in esophageal squamous cell carcinoma.
    Hou G; Jia A; Yang L; Zhao Y; Hu Y; Zhao W; Zhao W; Liu HM; Lu Z
    Mol Cell Biochem; 2020 Sep; 472(1-2):219-230. PubMed ID: 32671513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Scutellarin Suppresses Patient-Derived Xenograft Tumor Growth by Directly Targeting AKT in Esophageal Squamous Cell Carcinoma.
    Liu F; Zu X; Xie X; Zhang Y; Liu K; Chen H; Wang T; Bode AM; Dong Z; Kim DJ
    Cancer Prev Res (Phila); 2019 Dec; 12(12):849-860. PubMed ID: 31554627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Xerophilusin B induces cell cycle arrest and apoptosis in esophageal squamous cell carcinoma cells and does not cause toxicity in nude mice.
    Yao R; Chen Z; Zhou C; Luo M; Shi X; Li J; Gao Y; Zhou F; Pu J; Sun H; He J
    J Nat Prod; 2015 Jan; 78(1):10-6. PubMed ID: 25555195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-tumor activity of oridonin on SNU-5 subcutaneous xenograft model via regulation of c-Met pathway.
    Liu H; Qian C; Shen Z
    Tumour Biol; 2014 Sep; 35(9):9139-46. PubMed ID: 24916572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oridonin inhibits hypoxia-induced epithelial-mesenchymal transition and cell migration by the hypoxia-inducible factor-1α/matrix metallopeptidase-9 signal pathway in gallbladder cancer.
    Chen K; Ye J; Qi L; Liao Y; Li R; Song S; Zhou C; Feng R; Zhai W
    Anticancer Drugs; 2019 Oct; 30(9):925-932. PubMed ID: 31517732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oridonin inhibits epithelial-mesenchymal transition of human nasopharyngeal carcinoma cells by negatively regulating AKT/STAT3 signaling pathway.
    Liu W; Huang G; Yang Y; Gao R; Zhang S; Kou B
    Int J Med Sci; 2021; 18(1):81-87. PubMed ID: 33390776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.